MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment. (MOONSI)

November 7, 2022 updated by: Carolyn M Hettrich

This project will be a multi-center, prospective longitudinal cohort for all patients undergoing primary shoulder instability surgery, excluding isolated SLAP repairs. We will be looking for risk factors for recurrent instability, revision surgery, and poor outcomes. Patients will be asked to complete the RAND-36, ASES, Shoulder Activity, EQ-5D and WOSI outcome measures, as well as demographic and socioeconomic information. Surgeons will complete a form after surgery with information on radiographic findings, physical exam, surgical findings, and the repair. Patients will wear a sling post-operatively, and follow standardized rehabilitation protocols, including physical therapy.

Patients will be sent outcome questionnaires at 2, 6, 10, and 20 years after surgery.

Study Overview

Detailed Description

The objective of this prospective multicenter cohort study of patients undergoing surgery for glenohumeral instability is to identify the outcomes, and more importantly, the previously unknown predictors of sports function, activity level, general health, recurrent instability symptoms, and surgical failures following surgery. Patient information at the time of the surgery (demographics, validated outcome measures), in addition to the physical exam findings, shoulder pathology at the time of surgery, and surgical treatment will be obtained. The validated outcome instruments are American Shoulder and Elbow Surgeons Score, Western Ontario Shoulder Instability, Kerlan Jobe Overhand Athlete Score, Shoulder Activity Score, and RAND-36. Post-operative physical exam data will be obtained at 6 months after surgery. Patient reported outcomes will be repeated at 2, 6, 10, and 20 years post-operatively. Our multivariable analysis will identify which of the many factors related to the injury, intra-operative treatment, postoperative care, physical patient characteristics, and behavioral patient characteristics contribute to recurrence and poor outcome.

Study Type

Observational

Enrollment (Anticipated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • San Francisco, California, United States, 94158
        • Recruiting
        • UCSF Orthopedic Institute
        • Contact:
        • Principal Investigator:
          • Benjamin C Ma, MD
        • Sub-Investigator:
          • Brian T Feeley, MD
        • Sub-Investigator:
          • Alan Zhang, MD
        • Sub-Investigator:
          • Drew A Lansdown, MD
    • Colorado
      • Boulder, Colorado, United States, 80304
        • Recruiting
        • University of Colorado
        • Contact:
        • Principal Investigator:
          • Jonathan T Bravman, MD
        • Sub-Investigator:
          • Adam Siedl, MD
        • Sub-Investigator:
          • Rachel M Frank, MD
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • Recruiting
        • University of Iowa
        • Contact:
        • Principal Investigator:
          • Brian Wolf, MD, MS
        • Sub-Investigator:
          • Matthew Bollier, MD
    • Kentucky
      • Lexington, Kentucky, United States, 40536
        • Recruiting
        • University of Kentucky
        • Contact:
        • Principal Investigator:
          • Carolyn M Hettrich, MD, MPH
        • Sub-Investigator:
          • Scott Mair, MD
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Recruiting
        • Brigham and Women's Hospital
        • Principal Investigator:
          • Carolyn M Hettrich, MD, MPH
        • Contact:
    • Michigan
      • Ann Arbor, Michigan, United States, 48109-0328
        • Recruiting
        • University of Michigan
        • Contact:
        • Principal Investigator:
          • Bruce S Miller, MD
        • Sub-Investigator:
          • James E Carpenter, MD
        • Sub-Investigator:
          • John A. Grant, MD
    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Recruiting
        • Washington University
        • Contact:
        • Principal Investigator:
          • Robert H Brophy, MD
        • Sub-Investigator:
          • Rick W Wright, MD
        • Principal Investigator:
          • Matthew V Smith, MD
    • New York
      • New York, New York, United States, 10021
        • Active, not recruiting
        • Hospital for Special Surgery
    • Ohio
      • Columbus, Ohio, United States, 43221
        • Recruiting
        • Ohio State University
        • Contact:
        • Principal Investigator:
          • Grant L Jones, MD
        • Principal Investigator:
          • Julie Y Bishop, MD
        • Principal Investigator:
          • Andrew Neviaser, MD
    • South Dakota
      • Sioux Falls, South Dakota, United States, 57105
        • Recruiting
        • Orthopedic Institute
        • Contact:
          • Jillian Doty
          • Phone Number: 605-977-6848
        • Principal Investigator:
          • Keith Baumgarten
    • Tennessee
      • Nashville, Tennessee, United States, 37232-8774
        • Recruiting
        • Vanderbilt University
        • Contact:
          • Brooke Rode
        • Principal Investigator:
          • John E Kuhn, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 99 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Potential subjects are patients who are undergoing surgery of the labrum and/or capsule for shoulder instability

Description

Inclusion Criteria:

This is a prospective cohort study; there is no control group. Subjects that are included are all patients undergoing surgery for shoulder instability.

Inclusion criteria:

  • Anterior, posterior, and inferior instability
  • Ages 12-99
  • Open and arthroscopic repair
  • Revision of a previous shoulder instability repair
  • Latarjet/bone augmentation

Exclusion Criteria:

  • Workers compensation patients
  • Prisoners
  • Non-English speaker
  • Not mentally competent
  • Unable/unwilling to return for clinical follow-up
  • Arthroplasty patients
  • Rotator cuff tears
  • Fractures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
MOON Shoulder Instability
Patients indicated for Shoulder Instability surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictors of worse patient outcomes (pain and/or reduced quality of life).
Time Frame: 2 years, 6 years, 10 years and 20 years
Patients will fill out PRO's after surgery
2 years, 6 years, 10 years and 20 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictors for recurrent instability
Time Frame: 2 years, 6 years, 10 years and 20 years
Patients will be asked if they have had repeat surgery, recurrent dislocation, subluxation, as well as symptoms of instability on WOSI
2 years, 6 years, 10 years and 20 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictors of shoulder osteoarthritis
Time Frame: 6 years, 10 years and 20 years
Patients will fill out PRO's, symptomatic may return for xrays
6 years, 10 years and 20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2012

Primary Completion (ANTICIPATED)

December 31, 2022

Study Completion (ANTICIPATED)

December 1, 2042

Study Registration Dates

First Submitted

February 27, 2014

First Submitted That Met QC Criteria

February 28, 2014

First Posted (ESTIMATE)

March 3, 2014

Study Record Updates

Last Update Posted (ACTUAL)

November 9, 2022

Last Update Submitted That Met QC Criteria

November 7, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Other Instability, Shoulder

3
Subscribe